AGRANA Beteiligungs-Aktiengesellschaft (AGR)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 11.70 |
|---|---|
| 52-week range | 10.85 – 12.50 |
| Return, 1 month / 3 months | +3.5% / +1.7% |
| Return, 1 year / 3 years | −1.2% / −12.6% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 23.8% |
| Worst drawdown (1 year) | -11.7% |
| Average daily value traded | 0.11M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Agrana Beteiligungs-Aktiengesellschaft is an Austrian company that processes agricultural raw materials into food ingredients and industrial products. Its sugar business produces sugar and related products, its starch division makes starch and starch derivatives for food and technical uses, and its fruit segment supplies fruit preparations, fruit juice concentrates and related ingredients to food and beverage manufacturers. The company is based in Austria and serves customers in food processing and other industries across several countries.
On this site AGRANA Beteiligungs-Aktiengesellschaft appears as a stock on the Vienna Exchange (Austria), code AGR, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AGRANA Beteiligungs-Aktiengesellschaft (AGR) trades on the Vienna Exchange in Austria. It last closed at EUR 11.70 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 21 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.2% and over the last three months it rose 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -5.3% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.7% | ||
| 6-month return | 2.6% | ||
| 12-month return, skipping the last month | -4.5% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.7% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +3.5% |
| 3 months | +1.7% |
| 6 months | +2.6% |
| 1 year | −1.2% |
| 3 years | −12.6% |
| 5 years | −18.4% |
Signals
| 50-day / 200-day average | 11.41 / 11.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jul 2026 | EUR 0.3500 |
| 9 Jul 2025 | EUR 0.7000 |
| 10 Jul 2024 | EUR 0.9000 |
| 12 Jul 2023 | EUR 0.9000 |
| 13 Jul 2022 | EUR 0.7500 |
| 2 Jul 2021 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.